MediMabBio

Seongnam, South Korea · Founded 2017 · Privately Held (backing)

Developer of healthcare immunotherapies designed to treat serious diseases such as cancer and autoimmune disorders. MediMabBio is based in Seongnam, South Korea and was founded in 2017. It has raised $37.9 million.

Last price · $/share

—

Implied valuation

—

Total raised

$37.9M

Last round

—

How much has MediMabBio raised?

$37.9Macross 0 recorded rounds

Free account

More of MediMabBio with a free account

·The complete investor list: 19 names
·Watch MediMabBio: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

MediMabBio investors

19 investors are on record for MediMabBio, including Tech Incubator Program for Startup, KB Investment, Smilegate Investment and Posco Investment. By type, the record holds 6 venture capital firms and 1 hedge fund.

For fundraisers

Raising for a company like MediMabBio?

19 investors have backed MediMabBio.

See all 19 investors →

Frequently asked about MediMabBio

How much has MediMabBio raised?: MediMabBio has raised $37.9M in total across 0 recorded funding rounds.